2
LONG TERM CONDITION MANAGEMENT Reducing healthcare costs and/or improving quality of life for individuals with long term conditions by minimising their effects with integrative care and self management. MARKET OPPORTUNITY Globally, chronic diseases are responsible for 57% of all deaths annually, and the World Health Organisation (WHO) predicts that long term conditions will account for approximately 65% of all deaths (over 47 million deaths annually) by 2030. 30% of Americans live with long term conditions, and their healthcare costs account for more than 75% of the nation’s $2 trillion in medical spending. Britain remains one of the worst countries in Europe for cardiovascular disease, with more than 20,000 deaths annually. In Scotland, 2/5ths of the population has a long term condition CHRONIC CONDITIONS & DISEASE MANAGEMENT The UK economy stands to lose £16 billion over the next 10 years through premature deaths due to heart disease, stroke and diabetes. In the US from 1998 to 2008, the Disease Management industry exploded from a $120 million industry to a $2.2 billion one, a ten-year cumulative annual growth rate (CAGR) of 34%. KEY ISSUES Diabetes Diabetes results in long run complications that cost an estimated £1.3bn a year in the UK. The WHO predict that there will be 2.67 million people with diabetes in the UK by 2030 (1.76 million in 2000). It is predicted that the US will have 30.3 million diabetics in 2030 (17.7 million in 2000). 171 million people in the world had diabetes in 2000, this is predicted to rise to 366 million by 2030. 8M 7M 6M 5M 4M 3M 2M 1M 0 Coronary Heart Disease Number Affected (million) Long Term Condition Heart Failure Stroke & Transient ischaemic attack Hypertension Diabetes COPD Epilepsy Cancer Severe mental health Asthma 14 12 10 8 6 4 2 0 2010 2030 Percentage of total population China France Germany Singapore United Kingdom United States World Prevalence of Diabetes (2010 versus 2030) Long Term Chronic Disease in England Top 5 Chronic Conditions are: Hypertension 6,706,000 Asthma 3,100,000 Diabetes 1,962,000 Coronary Heart Disease 1,899,000 Stroke & Transient ischaemic attack 863,000

Long Term Conditions Management

Embed Size (px)

DESCRIPTION

FACT Sheet

Citation preview

Page 1: Long Term Conditions Management

LONG TERM CONDITION MANAGEMENT

Reducing healthcare costs and/or improving quality of life for individuals with long term conditions by minimising their effects with integrative care and self management.

MARKET OPPORTUNITY

Globally, chronic diseases are responsible for 57% of alldeaths annually, and the World Health Organisation (WHO) predicts that long term conditions will account forapproximately 65% of all deaths (over 47 million deathsannually) by 2030.

30% of Americans live with long term conditions, and theirhealthcare costs account for more than 75% of the nation’s$2 trillion in medical spending.

Britain remains one of the worst countries in Europe for cardiovascular disease, with more than 20,000 deaths annually.In Scotland, 2/5ths of the population has a long term condition

CHRONIC CONDITIONS & DISEASEMANAGEMENT

The UK economy stands to lose £16 billion over the next 10 years through premature deaths due to heart disease,stroke and diabetes.

In the US from 1998 to 2008, the Disease Managementindustry exploded from a $120 million industry to a $2.2 billion one, a ten-year cumulative annual growth rate (CAGR) of 34%.

KEY ISSUES

Diabetes• Diabetes results in long run complications that cost an

estimated £1.3bn a year in the UK.• The WHO predict that there will be 2.67 million people

with diabetes in the UK by 2030 (1.76 million in 2000). • It is predicted that the US will have 30.3 million diabetics

in 2030 (17.7 million in 2000).• 171 million people in the world had diabetes in 2000,

this is predicted to rise to 366 million by 2030.

8M

7M

6M

5M

4M

3M

2M

1M

0

Coron

ary

Heart

Diseas

e

Num

ber

Aff

ecte

d (m

illio

n)

Long Term Condition

Heart

Failu

re

Stroke

& Tr

ansie

nt

ischa

emic

atta

ck

Hyper

tens

ion

Diabet

es

COPD

Epilepsy

Cance

r

Sever

e men

tal

healt

hAsth

ma

14

12

10

8

6

4

2

0

20102030

Per

cent

age

of

tota

l po

pul

atio

n

China

Fran

ce

Germ

any

Singap

ore

United

King

dom

United

Sta

tes

Wor

ld

Prevalence of Diabetes (2010 versus 2030)

Long Term Chronic Disease in England

Top 5 Chronic Conditions are:Hypertension 6,706,000Asthma 3,100,000Diabetes 1,962,000Coronary Heart Disease 1,899,000Stroke & Transient ischaemic attack 863,000

Page 2: Long Term Conditions Management

LONG TERM CONDITION MANAGEMENT

Discuss it with my doctor

Became more involved in fitness activity

Look up information on the web

Examined diet and nutritional information

Look for a prescription drug

Nothing/not much

Search for a program or programs that helpme control and manage this condition

Started measuring vital signs andcollect data for self care

Stopped smoking

Joined an online or local supportgroup to learn and share

Joined a care management programavailable through my insurer/employer

Others

52%

% indicating actions

29%

27%

26%

23%

17%

12%

8%

7%

3%

3%

15%

KEY ISSUES (continued)

COPD• In the UK, COPD costs the NHS about £1bn a year.• In 2007 210 million people in the world had COPD and

3 million people died of COPD in 2005.• WHO predicts that COPD will become the third leading

cause of death worldwide by 2030.

Coronary Heart Disease• The annual cost of treating coronary heart disease is

£3.5bn for the UK with additional costs of £3.1bn dueto lost working days.

• Cardio Vascular Disease is the main cause of death inthe European Union, killing over 2 million people eachyear and costing the EU economy over €192 billionannually.

• In the US alone, heart disease and stroke are estimatedto have cost $448.5 billion in 2008.

• It is estimated that 17 million people die of CVDs[worldwide], particularly heart attacks and strokes,

One in six consumers with a chronic conditiondo nothing about their conditions thereforeproactive measures are needed.

Wellness & Health Innovation Client

DAN MEDICAL

We develop and manufacture state-of-the-art medicaldiagnostic and monitoring systems. Established in2002, our range of products is based around theDanMedical Analysis System, known as D-MAS.With advanced features, including integration withpatient record systems, local interpretation, encryptedemail, real-time connectivity anywhere in the worldand video conferencing capability, D-MAS possessesoutstanding eHealth and telemedicine applications.The WHI project made a real difference toDanMedical. We use it regularly and it has helped us to grow our business.

www.danmedical.info

To access our FREE services contact:Wellness and Health Innovation www.wellnesshealthinnovation.orgTel: 0845 607 8787 Email: [email protected]

©2011 Wellness and Health Innovation